Our board moves wrap includes Michael Edwards, Chris Hansen, Evan Hayes, and Paula Raffo.
Auroch Minerals has appointed Michael Edwards as non-executive director, following the resignation of Chris Hansen. Mr Edwards is a geologist and economist with over 20 years of experience in senior management within the private and public sectors.
MGC Pharmaceuticals, a European-based biopharma company specialising in the production and development of phytocannabinoid-derived medicines, has appointed Evan Hayes as an independent non-executive director and strategic advisor. Mr Hayes is a highly experienced board member and has over 20 years of commercial and leadership experience within the healthcare and biotechnology sectors. He will advise on the global commercialisation strategy of the company’s cannabinoid medicine products.